Glenmark Life Sciences Ltd. - Research Center
543322 GLS Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Sales | 536.60 | 572.80 | 595.36 | 578.45 | 621.32 |
| Operating profit | 141.45 | 172.56 | 167.08 | 193.16 | 206.43 |
| Interest | 0.36 | 0.39 | 0.40 | 0.40 | 0.12 |
| Gross profit | 144.21 | 173.86 | 172.05 | 194.62 | 209.15 |
| EPS (Rs) | 7.99 | 9.69 | 9.69 | 11.05 | 11.95 |
Quarterly
results in details
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Other income | 3.13 | 1.69 | 5.37 | 1.85 | 2.84 |
| Stock adjustment | -9.14 | -0.93 | 3.68 | -50.17 | -19.37 |
| Raw material | 247.84 | 243.13 | 269.40 | 298.21 | 299.74 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 72.26 | 71.05 | 66.71 | 48.13 | 43.81 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 84.20 | 87.00 | 88.49 | 89.12 | 90.70 |
| Provisions made | - | - | - | - | - |
| Depreciation | 14.53 | 13.18 | 13.13 | 12.61 | 11.52 |
| Taxation | 31.74 | 41.92 | 40.19 | 46.55 | 51.27 |
| Net profit / loss | 97.94 | 118.77 | 118.74 | 135.45 | 146.36 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 24.51 | 24.51 | 24.51 | 24.51 | 24.51 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 26.36 | 30.12 | 28.06 | 33.39 | 33.22 |
| GPM (%) | 26.72 | 30.26 | 28.64 | 33.54 | 33.51 |
| NPM (%) | 18.15 | 20.67 | 19.77 | 23.34 | 23.45 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis